Adaptimmune Therapeutics PLC (ADAP)

0.8246 +0.02 (+3.10%) USD  |  NASDAQ  |  Nov 04, 16:00
0.8246 0.00 (0.00%) After-Hours: 20:00
More

Adaptimmune Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for ADAP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Revenues Data

View and export this data back to 2016. Upgrade now.
Date Value
November 01, 2024 --
October 31, 2024 --
October 30, 2024 --
October 29, 2024 --
October 28, 2024 --
October 25, 2024 --
October 24, 2024 --
October 23, 2024 --
October 22, 2024 --
October 21, 2024 --
October 18, 2024 --
October 17, 2024 --
October 16, 2024 --
October 15, 2024 --
October 14, 2024 --
October 11, 2024 --
October 10, 2024 --
October 09, 2024 --
October 08, 2024 --
October 07, 2024 --
October 04, 2024 --
October 03, 2024 --
October 02, 2024 --
October 01, 2024 --
September 30, 2024 --
Date Value
September 27, 2024 --
September 26, 2024 --
September 25, 2024 --
September 24, 2024 --
September 23, 2024 --
September 20, 2024 --
September 19, 2024 --
September 18, 2024 --
September 17, 2024 --
September 16, 2024 --
September 13, 2024 --
September 12, 2024 --
September 11, 2024 --
September 10, 2024 --
September 09, 2024 --
September 06, 2024 --
September 05, 2024 --
September 04, 2024 --
September 03, 2024 --
August 30, 2024 --
August 29, 2024 --
August 28, 2024 --
August 27, 2024 --
August 26, 2024 --
August 23, 2024 --

EV to Revenues Range, Past 5 Years

Upgrade
Minimum
Mar 15 2022
Upgrade
Maximum
Jun 04 2020
Upgrade
Average
Upgrade
Median

EV to Revenues Benchmarks

Biodexa Pharmaceuticals PLC Upgrade
Verona Pharma PLC --
NuCana PLC --
Autolus Therapeutics PLC --
Bicycle Therapeutics PLC Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade